SORRENTO THERAPEUTICS, INC. Share-based Payment Arrangement, Expense
SORRENTO THERAPEUTICS, INC. reported Share-based Payment Arrangement, Expense of $8.30 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2020-03-03
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2013-12-31 was $1.09M, a 336.97% increase year-over-year.
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2013-09-30 was $157.85K, a 663.13% increase year-over-year.
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2013-06-30 was $153.00K, a 447.67% increase year-over-year.
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2013-03-31 was $143.47K, a 436.77% increase year-over-year.
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2019 was $8.30M, a 33.87% increase from fiscal 2018.
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2018 was $6.20M, a 31.91% increase from fiscal 2017.
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2017 was $4.70M.
- SORRENTO THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2013 was $1.55M, a 375.46% increase from fiscal 2012.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 83 month | Share-based Payment Arrangement, Expense 86 month | Share-based Payment Arrangement, Expense 89 month | Share-based Payment Arrangement, Expense 95 month |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $8.30M 10-K · filed 2020-03-03 | |||||||
| 2018-12-31 | $6.20M 10-K · filed 2020-03-03 | |||||||
| 2017-12-31 | $4.70M 10-K · filed 2020-03-03 | |||||||
| 2013-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-01 | $1.25M derived: sum of 2 quarters · filed 2014-04-01 | $1.40M derived: sum of 3 quarters · filed 2014-04-01 | $1.55M 10-K · filed 2014-04-01 | $1.96M 10-K · filed 2014-04-01 | |||
| 2013-09-30 | $157.85K 10-Q · filed 2013-11-14 | $310.86K derived: sum of 2 quarters · filed 2013-11-14 | $454.32K 10-Q · filed 2013-11-14 | $703.93K derived: sum of 4 quarters · filed 2014-04-01 | $873.14K 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | $153.00K 10-Q · filed 2013-08-13 | $296.47K 10-Q · filed 2013-08-13 | $546.08K derived: sum of 3 quarters · filed 2014-04-01 | $566.76K derived: sum of 4 quarters · filed 2014-04-01 | $715.29K 10-Q · filed 2013-08-13 | |||
| 2013-03-31 | $143.47K 10-Q · filed 2013-05-15 | $393.08K derived: sum of 2 quarters · filed 2014-04-01 | $413.76K derived: sum of 3 quarters · filed 2014-04-01 | $441.70K derived: sum of 4 quarters · filed 2014-04-01 | $562.28K 10-Q · filed 2013-05-15 | |||
| 2012-12-31 | $249.61K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-01 | $270.29K derived: sum of 2 quarters · filed 2014-04-01 | $298.23K derived: sum of 3 quarters · filed 2014-04-01 | $324.96K 10-K · filed 2014-04-01 | $418.82K 10-K/A · filed 2013-03-27 | |||
| 2012-09-30 | $20.68K 10-Q · filed 2013-11-14 | $48.62K derived: sum of 2 quarters · filed 2013-11-14 | $75.35K 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | $27.94K 10-Q · filed 2013-08-13 | $54.66K 10-Q · filed 2013-08-13 | ||||||
| 2012-03-31 | $26.73K 10-Q · filed 2013-05-15 | |||||||
| 2011-12-31 | $42.29K 10-K/A · filed 2013-03-27 |